| Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment (NCT05677724) | Fubing Wang | 2022-07-01 |
| Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen (NCT05028322) | Central Hospital, Nancy, France | 2021-11-01 |
| Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation (NCT04942886) | Seoul St. Mary's Hospital | 2021-08-21 |
| The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs (NCT05001672) | Taipei Veterans General Hospital, Taiwan | 2021-08-15 |
| HCV, HBV, HIV Testing During Consultation With Anesthesiologist (NCT04286347) | Assistance Publique - Hôpitaux de Paris | 2021-08-05 |
| Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant (NCT05063071) | Fudan University | 2021-07-29 |
| Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases. (NCT05125458) | University of Campania Luigi Vanvitelli | 2021-04-01 |
| Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis (NCT05181332) | West China Hospital | 2021-01-01 |
| Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies (NCT04519710) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2020-09-15 |
| Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients (NCT04562051) | West China Hospital | 2020-09-10 |
| Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA (NCT04539119) | Ruijin Hospital | 2020-07-03 |
| The Impact of Tenofovir Alafenamide on Profiles of Body Weight and Metabolic Features in Chronic Hepatitis B Patients. (NCT04886336) | National Cheng-Kung University Hospital | 2020-06-04 |
| A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B (NCT04568265) | Ascentage Pharma Group Inc. | 2020-06-03 |
| Access HBV Assays - European Union (EU) Clinical Trial Protocol - (NCT04904835) | Beckman Coulter, Inc. | 2019-10-15 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus (NCT04059198) | F-star Therapeutics, Inc. | 2019-10-10 |
| Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBV (NCT05442437) | Zhongnan Hospital | 2019-09-08 |
| A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir (NCT04034368) | The First Hospital of Jilin University | 2019-08-01 |
| A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study) (NCT04054037) | Qin Ning | 2019-07-02 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor (NCT04023721) | F-star Therapeutics, Inc. | 2019-06-18 |
| Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients (NCT03932513) | F-star Therapeutics, Inc. | 2019-04-11 |
| Mechanism of DCs Dysfunction in Chronic HBV Infection (NCT03753308) | University Hospital, Grenoble | 2018-12-05 |
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects (NCT03239353) | Aucta Pharmaceuticals, Inc | 2017-10-20 |
| Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults (NCT03149627) | University of Alabama at Birmingham | 2017-06-07 |
| Chronic Hepatitis B Virus Infection in Zambia (NCT03158818) | University of Alabama at Birmingham | 2016-08-23 |
| A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT02826018) | Alnylam Pharmaceuticals | 2016-06-24 |
| Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease (NCT02658786) | Institute of Liver and Biliary Sciences, India | 2016-01-01 |
| Liver Fibrosis in Zambian HIV-HBV Co-infected Patients (NCT02344680) | University of Alabama at Birmingham | 2015-10-01 |
| A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses (NCT02434848) | Sheffield Teaching Hospitals NHS Foundation Trust | 2015-07-23 |
| Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China) (NCT02836236) | Gilead Sciences | 2015-06-19 |
| Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China) (NCT02836249) | Gilead Sciences | 2015-06-19 |
| Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women (NCT02044068) | Hopital Lariboisière | 2014-10-01 |
| Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults (NCT02071082) | Gilead Sciences | 2014-02-25 |
| Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy (NCT01970254) | M.D. Anderson Cancer Center | 2013-06-24 |
| Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy (NCT02039362) | Hopital Lariboisière | 2012-07-01 |
| A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B (NCT01590641) | Gilead Sciences | 2012-04-01 |
| Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV (NCT01637844) | Yi-Hua Zhou | 2012-04-01 |
| Impact of Hepatitis B Vaccination on HBs Antigenemia (NCT03193775) | Zagazig University | 2011-08-01 |
| Ultrasound Method to Measure Fibrosis of the Liver in Children (NCT02086708) | Massachusetts General Hospital | 2010-06-01 |
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (NCT00678587) | GlaxoSmithKline | 2008-06-01 |
| Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials (NCT01438424) | Bristol-Myers Squibb | 2001-01-01 |
| 'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT (NCT02454764) | Institute of Liver and Biliary Sciences, India | |